ZA774376B - Pharmaceutical compositions having an action on the central nervous system - Google Patents

Pharmaceutical compositions having an action on the central nervous system

Info

Publication number
ZA774376B
ZA774376B ZA00774376A ZA774376A ZA774376B ZA 774376 B ZA774376 B ZA 774376B ZA 00774376 A ZA00774376 A ZA 00774376A ZA 774376 A ZA774376 A ZA 774376A ZA 774376 B ZA774376 B ZA 774376B
Authority
ZA
South Africa
Prior art keywords
action
pharmaceutical compositions
nervous system
central nervous
central
Prior art date
Application number
ZA00774376A
Inventor
G Bartholini
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA774376B publication Critical patent/ZA774376B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA00774376A 1976-07-20 1977-07-20 Pharmaceutical compositions having an action on the central nervous system ZA774376B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (en) 1976-07-20 1976-07-20 Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia

Publications (1)

Publication Number Publication Date
ZA774376B true ZA774376B (en) 1978-06-28

Family

ID=9175888

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00774376A ZA774376B (en) 1976-07-20 1977-07-20 Pharmaceutical compositions having an action on the central nervous system

Country Status (3)

Country Link
BE (1) BE856937A (en)
FR (1) FR2358881A1 (en)
ZA (1) ZA774376B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231099A (en) * 1991-04-15 1993-07-27 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs

Also Published As

Publication number Publication date
FR2358881B1 (en) 1980-10-03
FR2358881A1 (en) 1978-02-17
BE856937A (en) 1978-01-19

Similar Documents

Publication Publication Date Title
ZA771090B (en) Pharmaceutical compositions
JPS52125619A (en) Pharmaceutical vehicle
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
PT66622A (en) Pharmaceutical compositions
AU3111677A (en) Pharmaceutical compositions
NZ186147A (en) Sterolin pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
AU2609277A (en) Pharmaceutical compositions
GB1532697A (en) 2,3-dihydroergolines
PH14168A (en) 2,4-pyrrolidinediones
GB1557694A (en) 2,9 dichlorquinacridone
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
AU2574877A (en) Pharmaceutical compositions
ZA772612B (en) Pharmaceutical compositions
HK69380A (en) Pharmaceutical compositions
GB1554021A (en) 4,5-didehydroprostaglandins
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
ZA774376B (en) Pharmaceutical compositions having an action on the central nervous system
PH13909A (en) 17(-acetylenic-androstenes,the pharmaceutical composition
HK3984A (en) Pharmaceutical compositions
ZA766301B (en) Substituted 2,1,3-benzothiadiazine
GB1554925A (en) 2,3-methyl-eneprostaglandins
GB1556567A (en) Pharmaceutical compositions having an action on the central nervous system